MTOR and Recurrent upper respiratory tract infections: Stomatitis, which occurred in approximately half the patients in the treatment group, including all the related terms, such as mouth ulceration, tongue ulceration, mucosal inflammation and gingival pain, was significantly associated with the use of mTOR inhibitors, unlike upper respiratory tract infections and nasopharyngitis.